La vendita allo scoperto per Custom Truck One Source dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Custom Truck One Source. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Custom Truck One Source (NYSE:CTOS) Azioni, Report sulle vendite allo scoperto

Custom Truck One Source

Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.

Custom Truck One Source, Inc. Common Stock

Custom Truck One Source Inc

Custom Truck One Source Inc Warrants (01/01/2025)

News

Reported Earlier, NOVAGOLD Announces Proposed Public Offering Of Up To 43.5M Common Shares

The Company intends to apply to list the Notes on the New York Stock Exchange ("NYSE") and, if the application is approved, expects trading in the Notes on NYSE to begin within 30 days after the Notes are first issued.

Reported Earlier, TWO Harbors Investment Prices $100M Public Offering Of 9.375% Senior Notes Due 2030

The U.K. and India have concluded a free trade agreement after three years of intermittent negotiations, with the aim of boosting bilateral trade by $34 billion by 2040.
What Happened:&nbsp;The deal between the world&#8217;s fifth and sixth largest economies comes in the wake of tariff chaos sparked by U.S. President Donald Trump. The agreement is anticipated to reduce&nbsp;tariffs on goods such as&nbsp;whisky and create opportunities for British companies in India and Indian workers in the U.K, reported Reuters.
Indian Prime Minister&nbsp;Narendra Modi&nbsp;characterized the deal as &#8220;ambitious and mutually beneficial,&#8221; while British Prime Minister&nbsp;Sir Keir Starmer&nbsp;praised it as a &#8220;new era for trade.&#8221;
This deal marks India&#8217;s step towards liberalizing its traditionally protected markets, including the automotive sector, and sets a benchmark for its future interactions with major Western powers. For the U.K., this is the most substantial trade agreement since its exit from the European Union in 2020.
India&#8217;s trade ministry announced that under the agreement, 99% of Indian exports—including textiles—will be exempt from duties. In contrast, the U.K. will see tariff reductions on 90% of its tariff lines.
The deal is expected to boost the UK's annual economic output by £4.8 billion ($6.41 billion) by 2040—a modest yet significant gain relative to the country's £2.6 trillion ($3.47 trillion) GDP in 2024.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/events/25/04/44971154/trump-fails-to-impress-americas-young-shows-poll-as-they-still-favor-biden-only-15-think-us-on-right-track" target="_blank" rel="noreferrer noopener">Trump Fails To Impress America&#8217;s Young, Shows Poll As They Still Favor Biden — Only 15% Think US On Right Track &#8211; Benzinga</a>
Why It Matters:&nbsp;Interestingly, the landmark deal between the U.K. and India comes at a time when a concrete deal between the U.S. and India is highly awaited. 
A few weeks back, U.S. Vice President JD Vance visited India, wherein he finalized terms for a trade negotiation, aiming to double bilateral trade between the U.S. and India to $500 billion by the end of the decade. Meanwhile, U.S. Treasury Secretary Scott Bessent has reiterated several times that India could be the first country to sign a trade deal with the U.S.
Notably, President Trump told reporters on Tuesday that India has offered to drop all tariffs on American imports. &#8220;They&#8217;ve already agreed. They would have never done that for anybody else but me,&#8221; asserted Trump. 
India, however, has not issued any official statements on the matter, as trade negotiations with the U.S. are still ongoing.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/25/05/45241770/india-fires-missiles-into-pakistani-territory-trump-hopes-fighting-between-nuclear-rivals-ends-very-quickly" target="_blank" rel="noreferrer noopener">India Fires Missiles Into Pakistani Territory, Trump Hopes Fighting Between Nuclear Rivals &#8216;Ends Very Quickly&#8217; &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

UK, India Seal $34 Billion Free Trade Deal Amid Tariff Turmoil — As Trump Waits In The Wings

For April 2025, the total number of terminal passengers at GAP's 12 Mexican airports increased by 9.9%, compared to April 2024. Tijuana, Guadalajara, Los Cabos, and Puerto Vallarta airports presented an increase in passenger traffic of 10.0%, 9.0%, 8.7%, and 5.7% respectively, compared to April 2024. On the other hand, Montego Bay presented a decrease in passenger traffic of 1.3%, compared to April 2024.

Reported Earlier, Grupo Aeroportuario del Pacifico April 2025 Passenger Traffic Increased 9.1% Compared To 2024

MPLX

Reported Earlier, I Squared, MPLX, and Enbridge Announce Agreement to Acquire Equity Stakes in Matterhorn Express Pipeline From Ridgemont And Devon Energy

Johnson Controls International plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) will release earnings results for the second quarter, before the <a href="https://www.benzinga.com/quote/JCI/earnings">opening bell on Wednesday, May 7.</a>
Analysts expect the Cork, Ireland-based company to report quarterly earnings at 80 cents per share, up from 78 cents per share in the year-ago period. Johnson Controls International projects to report quarterly revenue at $5.66 billion, compared to $6.7 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On March 12, the company's board of directors approved a regular quarterly dividend of 37 cents per share of common stock.
Johnson Controls International shares fell 0.6% to close at $88.81 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/JCI/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Citigroup analyst Andrew Kaplowitz maintained a Neutral rating and cut the price target from $95 to $85 on April 14, 2025. This analyst has an accuracy rate of 81%.</li>
<li>JP Morgan analyst Stephen Tusa maintained an Overweight rating and cut the price target from $100 to $81 on April 8, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Barclays analyst Julian Mitchell maintained an Equal-Weight rating and slashed the price target from $88 to $85 on March 10, 2025. This analyst has an accuracy rate of 73%.</li>
<li>UBS analyst Amit Mehrotra upgraded the stock from Neutral to Buy and boosted the price target from $90 to $103 on Feb. 10, 2025. This analyst has an accuracy rate of 75%.</li>
<li>RBC Capital analyst Deane Dray maintained a Sector Perform rating and raised the price target from $86 to $93 on Feb. 6, 2025. This analyst has an accuracy rate of 69%.</li>
</ul>
Considering buying JCI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="568" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07031300/image-61-1024x568.png" alt="" class="wp-image-904917" style="width:552px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07031300/image-61-1024x568.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07031300/image-61-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07031300/image-61-768x426.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07031300/image-61.png 1132w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Earnings

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

Johnson Controls Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

<ul>
<li>Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations.</li>
<li>The collaboration continues a successful partnership on evaluating new treatment regimens aimed at reducing treatment duration and overcoming resistance to current therapies.</li>
</ul>

Evotec Secures $2.5M Grant To Generate Critical Data Supporting New TB Regimens

<ul>
<li>DA-1241 Significantly Decreased Plasma ALT levels, with a Mean Reduction of 22.8 U/L After 16 Week-Treatment</li>
<li>Controlled Attenuation Parameter (CAP) Score Improved by 23.0 dB/m, Indicating Reduced Liver Fat Content</li>
<li>Improvement in Systemic Inflammatory and Fibrosis Biomarkers Supports Beneficial Effects on Liver Health</li>
</ul>

MTVA

MetaVia Presents Phase 2a Data at EASL 2025 Showing DA-1241, A GPR119 Agonist, Significantly Lowers ALT And Liver Fat An Presumed MASH Patients

Data highlighted in late-breaker poster presentation shows that imdusiran achieves functional cure in chronic hepatitis B (cHBV) patients when combined with VTP-300 and low dose nivolumab
In a Phase 1a/1b clinical trial, AB-101, an oral PD-L1 inhibitor, has shown to be generally safe and well-tolerated with evidence of high receptor occupancy and no liver dysfunction in cHBV patients

ABUS

Arbutus's Imdusiran Plus VTP-300 And Low-Dose Nivolumab Achieve HBsAg Loss And Seroconversion In cHBV Patients, New Phase 2a Data Reveal At EASL 2025

WKEY

WISeKey And OISTE.ORG Roll Out Post-Quantum Cryptography Root Key, Preparing Critical Systems For The Quantum Computing Era

– 60% of Participants with Prior Fibrate or Obeticholic Acid Treatment Achieve Biochemical Response with Livdelzi –
– New Evidence Supports Livdelzi Delivers Clinically and Statistically Significant Improvements in Pruritus –

GILD

Gilead Showcases Livdelzi's Efficacy And Tolerability In PBC, With 60% Response Rate Among Patients With Prior Fibrate Or OCA Use, At EASL 2025

DoorDash Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) is shifting its focus beyond food delivery, with CEO Tony Xu outlining plans during the company's earnings call to expand more broadly into local commerce through a range of new services and tech innovations.
What Happened: On Tuesday, during the company&#8217;s <a href="https://benzinga.com/news/earnings/25/05/45221705/doordash-is-hungry-for-growth-q1-orders-jump-18-plans-2-big-acquisitions-to-expand-international-presence">first quarter earnings</a> call, Xu spoke of the company&#8217;s goal of &#8220;connecting every local business to every local consumer,&#8221; before outlining how recent product moves, such as the DashPass membership program, the DoubleDash service, and its investments in autonomous deliveries fit into the same.
Xu sees a lot more potential in DashPass, beyond just the free deliveries that DoorDash users have come to expect. He calls it a &#8220;membership to the physical world,&#8221; designed to engage and offer a growing array of local services. &#8220;There would be no other program in which you would have more or gain more utility,&#8221; he says.
See More: <a href="https://www.benzinga.com/markets/25/05/45243129/nvidia-ceo-jensen-huang-says-losing-access-to-chinas-potential-50-billion-ai-market-would-be-a-tremendous-loss">Nvidia CEO Jensen Huang Says Losing Access To China&#8217;s Potential $50 Billion AI Market Would Be A &#8216;Tremendous Loss&#8217;</a>
DoubleDash, which allows users to shop from multiple stores in a single order with no added fees, will soon feature every retail catalog in their respective cities, according to Xu. He, however, adds that &#8220;we're still in the work of just getting the basics right.&#8221;
Xu says DoorDash will be rolling out its autonomous delivery tech in Los Angeles, which it continues to test in other markets. &#8220;You don't need a 4,000-pound vehicle to deliver a one- or two-pound item or package,&#8221; he says, while adding that the first and last &#8220;10 feet problem&#8221; still needs to be solved.
Why It Matters: The company recently entered into hemp-derived <a href="https://benzinga.com/markets/cannabis/25/02/43558897/exclusive-doordash-reveals-why-its-betting-on-thc-cbd-delivery">THC and CBD deliveries</a>, a niche which the company notes has high repeat purchases and basket sizes, since orders are often bundled with alcohol and snacks.
Early this week, the company announced its <a href="https://www.benzinga.com/25/05/45214764/doordash-to-boost-global-presence-with-nearly-39-billion-acquisition-of-uks-deliveroo">intent to acquire</a> European food delivery company, Deliveroo PLC (OTCMKTS:&nbsp;DROOF) in a $3.9 billion deal, which would allow the combined companies to serve 1 billion people across 40 different countries. 
DoorDash is already a dominant player in urban markets. Domino&#8217;s Pizza Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>), which was holding out against delivery services for years, finally made the decision to <a href="https://www.benzinga.com/news/earnings/25/04/45058659/dominos-is-fine-with-doordash-eyes-full-national-rollout-for-q2-ceo-says-pizza-giants-strategy-is-to-meet-customers-where-they-are">join the platform</a>, after realizing the incremental sales it can provide in the face of dropping same-store sales, calling third-party platforms a $1 billion opportunity for the company.
However, DoorDash's use of its dominant position to gain a competitive edge has come under scrutiny. Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), which operates rival platform Uber Eats, has filed a <a href="https://www.benzinga.com/25/02/43764119/uber-files-a-lawsuit-action-against-doordash-over-anticompetitive-conduct-underhanded-tactics-have-cost-uber-millions-of-dollars-in-revenue">lawsuit accusing DoorDash</a> of engaging in anticompetitive conduct for pressuring restaurants into exclusivity contracts. 
During its <a href="https://benzinga.com/news/earnings/25/05/45221705/doordash-is-hungry-for-growth-q1-orders-jump-18-plans-2-big-acquisitions-to-expand-international-presence">first quarter results</a> on Tuesday, DoorDash reported $3.03 billion in revenue, up 21% YoY, but missed top-line estimates at $3.09 billion. It posted a profit of $0.44 per share, ahead of consensus estimates at $0.39 per share.
Price Action: The stock was down 7.44% on Tuesday, following the company&#8217;s miss on revenue estimates, it is now up 0.75% after hours.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="134" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM-1024x134.png" alt="" class="wp-image-904763" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM-1024x134.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM-300x39.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM-768x100.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM-1536x200.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM.png 1610w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
According to Benzinga&#8217;s Edge Stock Rankings, DoorDash scores well on Momentum and Growth, while showing a favorable price trend in the short, medium, and long terms. For more insights, sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge</a>.
Photo Courtesy: rblfmr on Shutterstock.com
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45244190/microsoft-faces-fresh-revenue-hit-as-openai-plans-to-reduce-payouts-by-2030-report">OpenAI To Slash Microsoft Revenue Share By 2030: Report</a></li>
</ul>

DASH

UBER

DashPass, DoubleDash And Drones:  DoorDash Plans To 'Connect Every Local Business To Every Local Consumer'

Lucid Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) shared a comprehensive list of updates as well as forecasts at the Q1 2025 earnings call with investors.
What Happened: The EV maker announced $235 million in revenue, which, despite being a 36% YoY increase when compared to Q1 2024, was lower than the estimated $246 million. Lucid also announced -$0.20 Earnings Per Share (EPS), beating Wall Street estimates, the company reported at the earnings call on Tuesday evening.
"​​We delivered 3,109 vehicles, up more than 58% year over year and our fifth consecutive quarter of record deliveries," CEO Marc Winterhoff said. Winterhoff also highlighted a 28% YoY increase in production as the company produced 2,212 vehicles.
Lucid also experienced an increase in gross margins for the quarter. "On a GAAP basis, Q1 gross margin was negative 97.2%, up from negative 134.3% in the prior year quarter," Lucid's CFO, Tafiq Boussaid, shared with investors.
He also outlined an 8-15% impact on margins due to the uncertainties raised by U.S. President Donald Trump's tariffs. The company has also set a target of producing 20,000 units in 2025.
The company also shared its plans to develop a mid-size platform slated to enter production in 2026. "We are working right now with a very strong focus on midsize," Winterhoff said in the call.
Why It Matters: The updates outline what was a successful quarter for the company, which also recently <a href="https://www.benzinga.com/news/25/04/44757588/lucid-wins-nikola-bankruptcy-auction-buys-nikola-facilities-for-30-million-to-boost-us-ev-production">acquired some assets</a> from EV Trucking company Nikola Corp, as well as hiring over 300 employees of the company.
Lucid, which is owned by Saudi Arabia's Sovereign Wealth Fund PIF, had also <a href="https://www.benzinga.com/25/04/44626267/lucid-raises-1-billion-in-debt-offering-to-buy-back-2026-notes-and-boost-financial-flexibility">raised over $1 billion </a>via convertible senior notes earlier this year.
Lucid also <a href="https://www.benzinga.com/trading-ideas/technicals/25/05/45234062/rivian-charges-up-lucid-stuck-in-neutral-tesla-rivals-q1-earnings-face-off">partnered up with KAUST</a>, or King Abdullah University of Science and Technology, to develop advanced autonomous driving capabilities as well as AI hardware.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="205" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025-1024x205.jpg" alt="" class="wp-image-904796" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025-1024x205.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025-300x60.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025-768x154.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025-1536x307.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025.jpg 1621w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
LCID scores well on the Growth metric and has satisfactory scores on the Momentum and Value metrics. For more such insights, sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge</a> today!
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/05/45243985/rivian-holds-firm-on-45k-r2-price-despite-tariff-pressures-ceo-rj-scaringe-says-its-important-for-us-as-ev-maker-tops-q1-estimates">Rivian Holds Firm On $45K Price For Upcoming R2 Despite Tariff Pressures: CEO RJ Scaringe Says It&#8217;s &#8216;Important For Us&#8217; As EV Maker Tops Q1 Estimates&nbsp;</a></li>
</ul>
Photo courtesy: Ian Dewar Photography / Shutterstock.com

Tech

LCID

Tesla-Rival Lucid Announces 58% Increase In Deliveries, Plans To Introduce Mid-Size Platform In 2026

The data presented highlight the following: &nbsp;
<ul>
<li>Sustained improvements from baseline in the Unified Wilson Disease Rating Scale ("UWDRS") Part II (patient-reported symptoms) and Part III (clinician-assessed symptoms);</li>
<li>Increased copper mobilization as evidenced by a sustained increase in dNCC (directly measured non-ceruloplasmin-bound copper);</li>
<li>Improvements on the Clinical Global Impression –&nbsp;Improvement ("CGI-I") scale for ALXN1840 compared to standard of care;</li>
<li>Improvement in the New Wilson Index (based on bilirubin, AST, INR, leukocytes, and albumin) for patients treated with ALXN1840;</li>
<li>Higher patient-reported convenience and effectiveness of ALXN1840 compared to standard of care, including those who transitioned from standard of care to ALXN1840 in the extension portion of the Phase 3 clinical trial; and</li>
</ul>

MNPR

Monopar Presents ALXN1840 Late-Breaker Data At EASL 2025, Highlighting Long-Term Efficacy And Safety In Wilson Disease Across Three Clinical Trials

On Wednesday, Chamath Palihapitiya, a prominent investor and former executive at Facebook, shared insights on how to attain and maintain wealth. 
What Happened: He emphasized the importance of being adaptable in one&#8217;s thinking. Palihapitiya cautioned against clinging to ineffective ideas, which he believes can lead to mediocrity. He advised that changing one&#8217;s mind is crucial to staying ahead, suggesting that those who cannot adapt will try to anchor others to past opinions. Palihapitiya&#8217;s message encourages individuals to focus on future opportunities rather than past mistakes.
&#8220;Learn to change your mind and skate to where the puck is going to be,&#8221; said Palihapitiya while warning his followers on X that most ideas were inherently not good and staying &#8220;fixated&#8221; on them creates an &#8220;anchoring bias&#8221; which leads to mediocrity.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">If you'd like to get rich or stay rich, I'd encourage you to develop the ability to change your mind. Most ideas are shitty. So staying fixated on shitty ideas creates an anchoring bias that will weigh you down to the mediocrity of the masses. Learn to change your mind and…
&mdash; Chamath Palihapitiya (@chamath) <a href="https://twitter.com/chamath/status/1919785263670428066?ref_src=twsrc%5Etfw">May 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Interacting with a user on X who questioned the SPAC King about integrity and asked him whether he did not see a conflict in the position he was taking, he replied, &#8220;Change your mind! Win!&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Don't get caught up in others' philosophical underwear. Change your mind! Win!
&mdash; Chamath Palihapitiya (@chamath) <a href="https://twitter.com/chamath/status/1919792239733039182?ref_src=twsrc%5Etfw">May 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Palihapitiya&#8217;s comments align with his broader perspective on the changing landscape of work and skills. In a recent discussion, he <a href="https://www.benzinga.com/news/25/03/44549064/chamath-palihapitiya-agrees-you-should-no-longer-learn-to-code-says-parents-should-advise-their-kids">advised against learning to code</a>, predicting that the role of engineers might diminish as technology advances. 
Palihapitiya&#8217;s insights are particularly relevant given his extensive experience and success in the tech and investment sectors. Palihapitiya&#8217;s net worth, <a href="https://www.benzinga.com/sec/insider-trades/0001715450/chamath-palihapitiya">estimated at $211 million</a> in November 2024, underscores his credibility in offering financial and career advice.
Photo Courtesy: Kathy Hutchins On Shutterstock.com
Read Next: 
<ul>
<li><a href="https://benzinga.com/25/05/45216185/microsoft-co-founder-bill-gates-says-trumps-climate-rollbacks-may-have-slowed-progress-but-americas-commitment-to" target="_blank" rel="noreferrer noopener">Bill Gates Says Trump&#8217;s Climate Rollbacks May Have Slowed Progress, But Microsoft Co-Founder Doesn&#8217;t Think &#8216;That&#8217;s a Permanent Thing&#8217; As America&#8217;s Commitment To Clean Energy Remains Strong</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

General

Chamath Palihapitiya Says If You Like To 'Get Rich Or Stay Rich' You Need To Acquire This One Critical Skill: 'Develop The Ability...'

– 90% of Adults with Chronic Hepatitis Delta Virus (HDV) who Achieved Undetectable HDV RNA at 96 Weeks of Treatment with Bulevirtide Remained Undetectable for Almost 2 Years After Stopping Treatment –

Gilead's Bulevirtide Shows Durability In Chronic HDV, With 90% of Patients on Long-Term Therapy Maintaining Undetectable HDV RNA Off-Treatment

<ul>
<li>Daiichi Sankyo and AstraZeneca's ENHERTU followed by THP showed an improved safety profile versus standard of care</li>
<li>First phase 3 trial to demonstrate benefit of ENHERTU in early breast cancer</li>
<li>Results will be shared with regulatory authorities</li>
</ul>

DSNKY

AstraZeneca And Daiichi Sankyo's ENHERTU Achieves Significant pCR Gains With Improved Safety Profile In Early HER2 Positive Breast Cancer Patients

MSFT

Microsoft Teams With National FFA To Equip Over 1 Million Students With Smart Sensor Tech And Precision Agriculture Tools

<ul>
<li>For the 2025 outlook, sales growth is now expected to be 13-21% at CER, and operating profit growth is now expected to be 16-24% at CER. Sales and operating profit growth reported in Danish kroner is now expected to be 3 and 5 percentage points lower than at CER, respectively. The updated sales outlook reflects lower-than-planned penetration of branded GLP-1 treatments in the US, impacted by compounded GLP-1s. Novo Nordisk is focused on preventing unlawful compounding and further expanding access in the US. With around 1 billion people living with obesity globally and only few million on treatment, Novo Nordisk continues the global roll-out of Wegovy&#xAE;.</li>
</ul>

Guidance

Novo Nordisk Lowers 2025 Outlook: Sales Growth Now Seen At 13–21% (Prior 16%–24%) At CER and Operating Profit at 16–24% (Priro 19%–27%) At CER, Citing Weaker Branded GLP-1 Uptake Amid Rapid US Compounding Expansion

Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.90 by 2.22 percent. This is a 10.84 percent increase over earnings of $0.83 per share from the same period last year. The company reported quarterly sales of $10.89 billion which missed the analyst consensus estimate of $11.64 billion by 6.44 percent. This is a 14.43 percent increase over sales of $9.52 billion the same period last year.

Earnings Beats

Earnings Misses

Novo Nordisk Q1 EPS $0.92 Beats $0.90 Estimate, Sales $10.89B Miss $11.64B Estimate

Press Releases

Custom Truck One Source to Announce Third Quarter 2024 Financial Results

Custom Truck One Source, Inc. Reports Third Quarter 2024 Results and Updates Full-Year Guidance

Custom Truck One Source to Participate in the BofA Securities 2024 Leveraged Finance Conference

Custom Truck One Source Announces Fourth Quarter and Full-Year 2024 Earnings Release and Conference Call

Custom Truck One Source to Participate in the 2025 J.P. Morgan Industrials Conference

Custom Truck One Source, Inc. Reports Fourth Quarter and Full-Year 2024 Results

Custom Truck One Source Showcases Load King Turbo Loader at WWETT 2025

Custom Truck One Source Announces First Quarter 2025 Earnings Release and Conference Call

Custom Truck One Source, Inc. Reports First Quarter 2025 Results and Reaffirms 2025 Guidance

Custom Truck One Source to Participate in the Oppenheimer 20th Annual Industrial Growth Conference

CTOS

Alta Equipment Group Inc. Class A Common Stock

Alta Equipment Group

Boise Cascade

BlueLinx Hldgs

Euro Tech Holdings Company Limited - Ordinary Shares

Euro Tech Hldgs

Dnow

Distribution Solutions Group, Inc. - Common Stock

Distribution Solns Gr

DXP Enterprises

EVI Industries

Global Industrial

Hudson Technologies

H&E Equipment Services, Inc. - Common Stock

H&E Equipment Servs

Herc Holdings

iPower

Karat Packaging

Lavoro

McGrath RentCorp

MRC Global

Marwynn Holdings

Simpple

Titan Machinery

Transcat

Willis Lease Finance Corporation - Common Stock

Willis Lease Finance

Xometry

ZKH Group Limited American Depositary Shares, each representing thirty-five (35) Class A Ordinary Shares

Comments

Custom Truck One Source

Vendite allo scoperto

Custom Truck One Source (NYSE:CTOS) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO